ERBB2 and breast neoplasm: The molecular features typically used for breast tumor subtyping include expression of the estrogen receptor (ER) and the progesterone receptor (PR), activation of human epidermal growth factor receptor 2 (HER2/neu, encoded by ERBB2), and/or the presence of BRCA1/2 mutations [3,4].